Tarek Omar Nafee, MD
Resident Physician
Department of Internal Medicine
Boston University School of Medicine
Research Fellow
Beth Israel Deaconess Medical Center
Biography
Dr. Tarek Nafee is an Internal Medicine Resident Physician at Boston University and a Post-doctoral Research Fellow at the PERFUSE Study Group in the Cardiovascular Division of Beth Israel Deaconess Medical Center in Boston.
Dr. Nafee received his BSc. in Biomedical Sciences from the University of Waterloo, Canada. He received his M.D. in from the ASU College of Medicine in St. Vincent & The Grenadines. He is a proud graduate of the Principles and Practice of Clinical Research Program (2015) and has been a Teaching Assistant for the program for the last 4 years. He graduated with a MMSc. Degree in Clinical Investigation from Harvard Medical School.
Tarek holds over 5 years of experience working in the pharmaceutical industry on phase I and phase II multinational randomized trials as well as 4 years working on phase III multicentered randomized cardiovascular mega trials as part of an academic research organization. He has published more than 30 peer reviewed articles and book chapters. He is the honorary recipient of the 2018 European Society of Cardiology Young Investigator Award in Thrombosis for his work on the use of artificial intelligence for the prediction venous thromboembolism in acutely ill patients.
Dr. Nafee has a passion for novel medical education platforms that are in line with 21st century learning paradigms. He currently holds positions as Associate Editor-in-Chief at Wikidoc.org, the Managing Editor at CardiologyNowNews.org and International Correspondent at Clinicaltrialresults.org, bringing live coverage from major cardiovascular conferences worldwide.
Clinically, his interests lie in the prevention of cardiovascular disease. Dr. Nafee is the co-founder of the Cardio-Oncology Clinic at the Roger Williams Medical Center, whereby newly diagnosed cancer patients undergo screening and follow up for cardiovascular adverse effects of chemotherapeutic agents.